How many patents does
Avi Biopharma have?
patents
486
families
57
granted
152
applications
334
US
154
EP
80
JP
28
WO
25
CN
14
KR
12
RoW
173
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Avi Biopharma
Top ten assignees appearing on patents
2009 - 2018
| avi biopharma | 231 |
| sarepta therapeutics | 208 |
| serepta therapeutics | 2 |
| avi biopharm | 1 |
2009
| avi biopharma | 44 |
| sarepta therapeutics | 1 |
| avi biopharm | 1 |
2018
| sarepta therapeutics | 31 |
Avi Biopharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| multiple exon skipping compositions for dmd | 51 | 2008 |
| oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | 27 | 2010 |
| method of synthesis of morpholino oligomers | 26 | 2007 |
| antisense antiviral compound and method for treating influenza viral infection | 24 | 2009 |
| oligonucleotide analogs having cationic intersubunit linkages | 21 | 2006 |
| antisense antibacterial method and compound | 19 | 2004 |
| tissue specific peptide conjugates and methods | 19 | 2007 |
| antisense antiviral compounds and methods for treating a filovirus infection | 19 | 2010 |
| peptide oligonucleotide conjugates | 18 | 2009 |
| compositions for enhancing transport and antisense efficacy of nucleic acid analog into … 🛈 | 15 | 2003 |